Expert reviews tagged with “dyslipidemia”

Dyslipidemia

Pursuing the Next Step in Reduction of Residual CV Risk

CHAPTER 1: Lipid Lowering: The Road to Current Treatment Guidelines

Jean C. Grégoire, MD, FRCPC, FACC
Cardiologist Montreal Heart Institute Associate Professor of Medicine
Université de Montréal, Montreal, QC

CHAPTER 2: The Development and Promise of PCSK9 Inhibitors

Nabil G. Seidah, OC, OQ, PhD, FRSC
Director, Laboratory of Biochemical Neuroendocrinology Clinical Research Institute of Montreal, Canada
Research Chair in Proteolysis Montreal, QC

CHAPTER 3: LDL-C Remains the Single Best Target for CV Risk Reduction

Milan Gupta, MD, FRCPC, FACC
Associate Clinical Professor of Medicine, McMaster University Assistant Professor of Medicine, University of Toronto Medical Director, Canadian Cardiovascular Research Network Toronto, ON

Download 18 PowerPoint slides
Dyslipidemia

Strategies Beyond Statins for Control of Dyslipidemias

Chapter 1: Care Gap: Reaching Guideline Goals

Jacques Genest, MD, FRCP(C)
Professor, Faculty of Medicine, McGill University
Novartis Chair in Medicine, McGill University
Scientific Director, Center for Innovative Medicine
McGill University Health Center/Royal Victoria Hospital
Montreal, Quebec

Chapter 2: Bile Acid Sequestrants: Rediscovering an Alternative to Statins

Robert A. Hegele, MD, FRCPC
Jacob J. Wolfe Distinguished Medical Research Chair
Edith Schulich Vinet Canada Research Chair (Tier 1) in Human Genetics
Martha Blackburn Chair in Cardiovascular Research
Distinguished University Professor of Medicine and Biochemistry
University of Western Ontario
London, Ontario

Chapter 3: Dyslipidemia in Patients with Type 2 Diabetes: Special Challenges

Vincent Woo, MD, FRCPC
University of Manitoba, Winnipeg, Manitoba

Download 12 PowerPoint slides

This web site is solely for healthcare professionals

Yes, I am a healthcare professional No, I am not a healthcare professional